CStone Pharmaceuticals
Jason Li has a diverse work experience in finance and consulting. Jason started their career as a Project Accountant Leader at CH2M HILL in 2005 and later worked as a Senior Analyst at Rockwell Automation from 2008 to 2009. In 2010, they joined Pas Advisors as a Senior Consultant and Account Manager. Jason then moved to Bayer in 2013, where they worked as a Controller. Currently, they are the Director of Finance at Geshi Pharmaceuticals, starting from 2016.
Jason Li received their Master of Business Administration (MBA) from Shanghai University of Finance and Economics in 2016. Jason previously attended Dongbei University of Finance and Economics from 2005 to 2009 and Shanghai Lixin University of Commerce from 2001 to 2004.
This person is not in any teams
CStone Pharmaceuticals
CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established at the end of 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. With a strategic emphasis on immuno-oncology combination therapies, the Company has built an oncology-focused pipeline of 16 drug candidates, including 5 late-stage candidates at pivotal trials or registration stages. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become a world-renowned biopharmaceutical company that is leading the way to conquering cancer.